Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eslam Saber Esmail

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|September 17, 2016
Sigmoid volvulus after caesarean sectionAsem Ahmed Elfert, Eslam Saber Esmail, Ibrahim Shibl S Eldin
Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|November 4, 2015
Low dose ribavirin has been effective in the treatment of incapacitating muco-cutaneous extrahepatic manifestations in patients with hepatitis C with contraindication or no access for approved antiviral treatmentEslam Saber Esmail, Fat-heyah Elsayed Asal, Mohammed Yussif, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 26, 2021
A Simple Scoring Model Predicting the Outcome of COVID-19 Patients: Tanta COVID ScoreMohammed Elhendawy, Ferial El-Kalla, Sherief Abd-Elsalam, et al.
Biological Trace Element Research|November 28, 2020
Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter TrialSherief Abd-Elsalam, Shaimaa Soliman, Eslam Saber Esmail, et al.
The American Journal of Tropical Medicine and Hygiene|August 24, 2020
RETRACTED: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled StudySherief Abd-Elsalam, Eslam Saber Esmail, Mai Khalaf, et al.
Biological Trace Element Research|March 21, 2024
Retraction Note: Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: A Randomized, Multicenter TrialSherief Abd-Elsalam, Shaimaa Soliman, Eslam Saber Esmail, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 19, 2020
Tanta Protocol for Management of COVID-19: Perspectives from a Developing CountrySherief Abd-Elsalam, Eslam Saber Esmail, Mai Khalaf, et al.
Hepatology International|July 6, 2020
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)Shiv Kumar Sarin, Ashok Choudhury, George K Lau, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|September 17, 2016
Sigmoid volvulus after caesarean sectionAsem Ahmed Elfert, Eslam Saber Esmail, Ibrahim Shibl S Eldin
Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|November 4, 2015
Low dose ribavirin has been effective in the treatment of incapacitating muco-cutaneous extrahepatic manifestations in patients with hepatitis C with contraindication or no access for approved antiviral treatmentEslam Saber Esmail, Fat-heyah Elsayed Asal, Mohammed Yussif, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 26, 2021
A Simple Scoring Model Predicting the Outcome of COVID-19 Patients: Tanta COVID ScoreMohammed Elhendawy, Ferial El-Kalla, Sherief Abd-Elsalam, et al.
Biological Trace Element Research|November 28, 2020
Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter TrialSherief Abd-Elsalam, Shaimaa Soliman, Eslam Saber Esmail, et al.
The American Journal of Tropical Medicine and Hygiene|August 24, 2020
RETRACTED: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled StudySherief Abd-Elsalam, Eslam Saber Esmail, Mai Khalaf, et al.
Biological Trace Element Research|March 21, 2024
Retraction Note: Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: A Randomized, Multicenter TrialSherief Abd-Elsalam, Shaimaa Soliman, Eslam Saber Esmail, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 19, 2020
Tanta Protocol for Management of COVID-19: Perspectives from a Developing CountrySherief Abd-Elsalam, Eslam Saber Esmail, Mai Khalaf, et al.
Hepatology International|July 6, 2020
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)Shiv Kumar Sarin, Ashok Choudhury, George K Lau, et al.
Pageof 1